The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Immunotoxins for targeted cancer therapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Huston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., & Crea, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5879 · Cited by 1,593
Single-Chain Antigen-Binding Proteins
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., & Whitlow, M. (1988) · Science · doi:10.1126/science.3140379 · Cited by 1,502
Uchiyama, T., Broder, S., & Waldmann, T. A. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.4.1393 · Cited by 1,329
Endo, Y., Mitsui, K., Motizuki, M., & Tsurugi, K. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45660-8 · Cited by 1,151
Keating, M. J., Flinn, I., Jain, V., Binet, J.-L., Hillmen, P., Byrd, J., Albitar, M., Brettman, L., Santabarbara, P., Wacker, B., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3554 · Cited by 948
Francisco, J. A., Cerveny, C. G., Meyer, D. L., Mixan, B. J., Klussman, K., Chace, D. F., Rejniak, S. X., Gordon, K. A., DeBlanc, R., Toki, B. E., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0039 · Cited by 931
The IL-2/IL-2 receptor system: A current overview
Taniguchi, T. (1993) · Cell · doi:10.1016/0092-8674(93)90152-g · Cited by 761
Chang, K., & Pastan, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.136 · Cited by 745
One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell
Yamaizumi, M., Mekada, E., Uchida, T., & Okada, Y. (1978) · Cell · doi:10.1016/0092-8674(78)90099-5 · Cited by 745
Robb, R. J., Greene, W. C., & Rusk, C. M. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.4.1126 · Cited by 725
The crystal structure of diphtheria toxin
Choe, S., Bennett, M. J., Fujii, G., Curmi, P. M. G., Kantardjieff, K. A., Collier, R. J., & Eisenberg, D. (1992) · Nature · doi:10.1038/357216a0 · Cited by 669
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
Harari, D., & Yarden, Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203973 · Cited by 633
Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Laske, D. W., Youle, R. J., & Oldfield, E. H. (1997) · Nature Medicine · doi:10.1038/nm1297-1362 · Cited by 525
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.
Allured, V. S., Collier, R. J., Carroll, S. F., & McKay, D. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1320 · Cited by 515
Cancer: Principles and Practice of Oncology
Steele, G. D. (1983) · Archives of Surgery · doi:10.1001/archsurg.1983.01390060092027 · Cited by 485
Kounnas, M. Z., Morris, R. E., Thompson, M. R., FitzGerald, D. J., Strickland, D. K., & Saelinger, C. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42291-0 · Cited by 447
Kreitman, R. J., Wilson, W. H., White, J. D., Stetler-Stevenson, M., Jaffe, E. S., Giardina, S., Waldmann, T. A., & Pastan, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1622 · Cited by 420
Self-citationA recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
Chaudhary, V. K., Queen, G., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., & Pastan, I. (1989) · Nature · doi:10.1038/339394a0 · Cited by 413
Buchner, J., Pastan, I., & Brinkmann, U. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90433-8 · Cited by 340
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas
Weaver, M., & Laske, D. W. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026246500788 · Cited by 299
Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells
Eiklid, K., Olsnes, S., & Pihl, A. (1980) · Experimental Cell Research · doi:10.1016/0014-4827(80)90270-0 · Cited by 298
Obiri, N. I., Debinski, W., Leonard, W. J., & Puri, R. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8797 · Cited by 263
Fitzgerald, D. J. P., Padmanabhan, R., Pastan, I., & Willingham, M. C. (1983) · Cell · doi:10.1016/0092-8674(83)90480-4 · Cited by 252
Sampson, J. H., Akabani, G., Archer, G. E., Bigner, D. D., Berger, M. S., Friedman, A. H., Friedman, H. S., Herndon II, J. E., Kunwar, S., Marcus, S., et al. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026290315809 · Cited by 239
Williams, D. P., Parker, K., Bacha, P., Bishai, W., Borowski, M., Genbauffe, F., Strom, T. B., & Murphy, J. R. (1987) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/1.6.493 · Cited by 236
Amlot, P., Stone, M., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., & Ghetie, V (1993) · Blood · doi:10.1182/blood.v82.9.2624.2624 · Cited by 235
Chowdhury, P. S., Viner, J. L., Beers, R., & Pastan, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.669 · Cited by 222
Rand, R. W., Kreitman, R. J., Patronas, N., Varricchio, F. E., Pastan, I. H., & Puri, R. K. (2000) · PubMed · Cited by 222
Self-citationBacha, P., Williams, D. P., Waters, C., Williams, J. M., Murphy, J. R., & Strom, T. B. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.612 · Cited by 220
Tsutsumi, Y., Onda, M., Nagata, S., Lee, B., Kreitman, R. J., & Pastan, I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140210597 · Cited by 216
Self-citationBrinkmann, U., Pai, L. H., FitzGerald, D. J., Willingham, M. C., & Pastan, I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8616 · Cited by 214
Debinski, W., Obiri, N. I., Pastan, I., & Puri, R. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16775 · Cited by 208
Wesche, J., Rapak, A., & Olsnes, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34443 · Cited by 203
Crystal Structure of Diphtheria Toxin Bound to Nicotinamide Adenine Dinucleotide
Bell, C. E., & Eisenberg, D. (1996) · Biochemistry · doi:10.1021/bi9520848 · Cited by 198
Sier, C. F. M., Stephens, R. W., Bízik, J., Mariani, A., Bassan, M., Pedersen, N. M., Frigerio, L., Ferrari, A. G., Danø, K., Brünner, N., et al. (1998) · PubMed · Cited by 191
Williams, D. P., Snider, C. E., Strom, T. B., & Murphy, J. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38482-0 · Cited by 185
LeMaistre, C. F., Saleh, M. N., Kuzel, T. M., Foss, F. M., Platanias, L. C., Schwartz, G. N., Ratain, M. J., Rook, A. H., Freytes, C. O., Craig, F. E., et al. (1998) · PubMed · doi:10.1182/blood.v91.2.399 · Cited by 184
Reconstitution of Diphtheria Toxin from Two Nontoxic Cross-Reacting Mutant Proteins
Uchida, T., Pappenheimer, A. M., & Harper, A. A. (1972) · Science · doi:10.1126/science.175.4024.901 · Cited by 176
Refined structure of monomelic diphtheria toxin at 2.3 Å resolution
Bennett, M. J., & Eisenberg, D. (1994) · Protein Science · doi:10.1002/pro.5560030912 · Cited by 175
Only high-affinity receptors for interleukin 2 mediate internalization of ligand.
Weissman, A. M., Harford, J. B., Svetlik, P. B., Leonard, W. L., Depper, J. M., Waldmann, T. A., Greene, W. C., & Klausner, R. D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.5.1463 · Cited by 174
Brinkmann, U., Brinkmann, E., Gallo, M., & Pastan, I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10427 · Cited by 173
Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin Selectivity
Greenfield, L., Johnson, V. G., & Youle, R. J. (1987) · Science · doi:10.1126/science.3498987 · Cited by 173
Moolten, F. L., & Cooperband, S. R. (1970) · Science · doi:10.1126/science.169.3940.68 · Cited by 167
Grossbard, M. L., Lambert, J. M., Goldmacher, V. S., Spector, N. L., Kinsella, J., Eliseo, L., Coral, F., Taylor, J. A., Blättler, W. A., & Epstein, C. L. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.726 · Cited by 159
Kunwar, S. (2003) · Local Therapies for Glioma Present Status and Future Developments · doi:10.1007/978-3-7091-6090-9_16 · Cited by 158
Thorpe, P. E., Wallace, P. M., Knowles, P. P., Relf, M., Brown, A. N., Watson, G., Blakey, D. C., & Newell, D. R. (1988) · PubMed · Cited by 155
Kreitman, R. J., & Pastan, I. H. (1995) · Biochemical Journal · doi:10.1042/bj3070029 · Cited by 154
Self-citationSalvatore, G., Beers, R., Margulies, I., Kreitman, R. J., & Pastan, I. H. (2002) · PubMed · Cited by 153
Self-citationNaito, K., Takeshita, A., Shigeno, K., Nakamura, S., Fujisawa, S., Shinjo, K., Yoshida, H., Ohnishi, K., Mori, M., Terakawa, S., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401851 · Cited by 153
Obiri, N. I., Leland, P., Murata, T., Debinski, W., & Puri, R. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.756 · Cited by 152
Kondo, T., FitzGerald, D. J., Chaudhary, V. K., et al. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)76564-8 · Cited by 147
Stone, M., Sausville, E., Fay, J. W. J., Headlee, D. J., Collins, R., Figg, W. D., Stetler-Stevenson, M. A., Jain, V. K., Jaffe, E., Solomon, D., et al. (1996) · Blood · doi:10.1182/blood.v88.4.1188.bloodjournal8841188 · Cited by 139
Kreitman, R. J., Bailon, P., Chaudhary, V. K., FitzGerald, D., & Pastan, I. (1994) · Blood · doi:10.1182/blood.v83.2.426.426 · Cited by 138
Self-citationPrinciples and Practice of the Biologic Therapy of Cancer
Rosenberg, S. A. (2000) · Cited by 136
Blakey, D. C., Watson, G., Knowles, P. P., et al. (1987) · PubMed · Cited by 132
Chiron, M. F., Fryling, C. M., & FitzGerald, D. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32431-6 · Cited by 129
Reiter, Y., Brinkmann, U., Kreitman, R. J., Jung, S., Lee, B., & Pastan, I. H. (1994) · Biochemistry · doi:10.1021/bi00184a014 · Cited by 128
Self-citationLemichez, E., Bomsel, M., Devilliers, G., van der Spek, J., Murphy, J. R., Lukianov, E. V., Olsnes, S., & Boquet, P. (1997) · Molecular Microbiology · doi:10.1111/j.1365-2958.1997.tb02669.x · Cited by 128
Pistillo, M. P. (2002) · Blood · doi:10.1182/blood-2002-06-1668 · Cited by 127
Messmann, R. A., Vitetta, E. S., Headlee, D. J., Senderowicz, A. M., Figg, W. D., Schindler, J. D., Michiel, D. F., Creekmore, S. P., Steinberg, S. M., Köhler, D., et al. (2000) · PubMed · Cited by 120
Study of the plasma clearance of antibody – ricin‐A‐chain immunotoxins
Bourrié, B., Casellas, P., Blythman, H., & Jansen, F. K. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09451.x · Cited by 115
Montagna, D., Yvon, E. S., Calcaterra, V., Comoli, P., Locatelli, F., Maccario, R., Fisher, A., & Cavazzana, M. (1999) · Blood · doi:10.1182/blood.v93.10.3550.410k24_3550_3557 · Cited by 114
Feuring‐Buske, M., Frankel, A. E., Alexander, R. L., Gerhard, B., & Hogge, D. E. (2002) · PubMed · Cited by 113
Frankel, A. E., Powell, B. L., Hall, P. D., Case, L. D., & Kreitman, R. J. (2002) · PubMed · Cited by 113
Self-citationTaniguchi, T., Kakkar, A. K., Tuddenham, E. G. D., Williamson, R. C. N., & Lemoine, N. R. (1998) · PubMed · Cited by 112
Azémar, M., Schmidt, M., Arlt, F., Kennel, P., Brandt, B., Papadimitriou, A., Groner, B., & Wels, W. S. (2000) · International Journal of Cancer · Cited by 104
Plesner, T., Ralfkiaer, E. M., Wittrup, M., Johnsen, H. E., Pyke, C., Pedersen, T. L., Hansen, N. E., & Danø, K. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.6.835 · Cited by 104
Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin’s lymphoma
Schnell, R., Borchmann, P., Staak, J. O., Schindler, J. D., Ghetie, V. F., Vitetta, E. S., & Engert, A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg209 · Cited by 100
Duvic, M. A., Kuzel, T. M., Olsen, E. A., Martin, A., Foss, F. M., Kim, Y. H., HEALD, P. W., Bacha, P., NICHOLS, J. C., & Liepa, A. M. (2002) · Clinical Lymphoma · doi:10.3816/clm.2002.n.003 · Cited by 99
Wels, W. S., Beerli, R. R., Hellmann, P., Schmidt, M., Marte, B. M., Корнилова, Е. С., Hekele, A., Mendelsohn, J. M., Groner, B., & Hynes, N. E. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600120 · Cited by 97
Bergamaschi, G., Perfetti, V., Tonon, L., Novella, A., Lucotti, C., Danova, M., Glennie, M. J., Merlini, G., & Cazzola, M. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1730.x · Cited by 97
Azémar, M., Djahansouzi, S., Jäger, E., Solbach, C., Schmidt, M., Maurer, A. B., Mross, K. B., Unger, C., von Minckwitz, G., Dall, P., et al. (2003) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000004371.48757.19 · Cited by 95
Vallera, D. A., Li, C., Jin, N., Panoskaltsis‐Mortari, A., & Hall, W. A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.597 · Cited by 95
Anti‐tumor effects of toxins targeted to the prostate specific membrane antigen
Fracasso, G., Bellisola, G., Cingarlini, S., Castelletti, D., Prayer‐Galetti, T., Pagano, F. C., Tridente, G., & Colombatti, M. (2002) · The Prostate · doi:10.1002/pros.10117 · Cited by 92
Grossbard, M., Gribben, J. G., Freedman, A. S., Lambert, J., Kinsella, J., Rabinowe, S. N., Eliseo, L. J., Taylor, J., Blättler, W. A., & Epstein, C. (1993) · Blood · doi:10.1182/blood.v81.9.2263.2263 · Cited by 91
Görgün, G., & Foss, F. M. (2002) · Blood · doi:10.1182/blood-2002-01-0300 · Cited by 86
Intraventricular Immunotoxin Therapy for Leptomeningeal Neoplasia
Laske, D. W., Muraszko, K. M., Oldfield, E. H., DeVroom, H. L., Sung, C., Dedrick, R. L., Simon, T. R., Colandrea, J., Copeland, C., Katz, D., et al. (1997) · Neurosurgery · doi:10.1097/00006123-199711000-00005 · Cited by 86
Frankel, A. E., Laver, J. H., Willingham, M. C., Burns, L. J., Kersey, J. H., & Vallera, D. A. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709051778 · Cited by 84
Lambert, J. M., McIntyre, G., Gauthier, M. N., Zullo, D., Rao, V., Steeves, R. M., Goldmacher, V. S., & Blattler, W. A. (1991) · Biochemistry · doi:10.1021/bi00227a011 · Cited by 82
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin
Schnell, R., Vitetta, E. S., Schindler, J. D., Borchmann, P., Barth, S., Ghetie, V. F., Hell, K., Drillich, S., Diehl, V., & Engert, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401626 · Cited by 75
Baluna, R. G., Coleman, E. J., Jones, C. D., Ghetie, V. F., & Vitetta, E. S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4954 · Cited by 74
Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
Lynch, T. J., Lambert, J., Coral, F., Shefner, J. M., Wen, P. Y., Blättler, W. A., Collinson, A. R., Ariniello, P. D., Braman, G. M., Cook, S., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.723 · Cited by 70
Hassan, R., Lerner, M. R., Benbrook, D. M., Lightfoot, S. A., Brackett, D. J., Wang, Q.-C., & Pastan, I. H. (2002) · PubMed · Cited by 70
Peipp, M., Küpers, H., Saul, D., Schlierf, B., Greil, J., Zunino, S. J., Gramatzki, M., & Fey, G. H. (2002) · PubMed · Cited by 70
Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., & Pastan, I. (1995) · PubMed · Cited by 69
Kreitman, R. J., Hansen, H. J., Jones, A. L., et al. (1993) · PubMed · Cited by 69
Self-citationBolognesi, A., Polito, L., Tazzari, P. L., Lemoli, R. M., Lubelli, C., Fogli, M., Boon, L., Boer, M. D., & Stirpe, F. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02193.x · Cited by 68
Onda, M., Nagata, S., Tsutsumi, Y. M., et al. (2001) · PubMed · Cited by 67
Crystal Structure of Diphtheria Toxin Bound to Nicotinamide Adenine Dinucleotide
Bell, C. E., & Eisenberg, D. S. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8632-0_4 · Cited by 66
Todhunter, D. A., Hall, W. A., Rustamzadeh, E., Shu, Y., Doumbia, S., & Vallera, D. A. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh023 · Cited by 65
Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.
Hagihara, N., Walbridge, S., Olson, A. W., Oldfield, E. H., & Youle, R. J. (2000) · PubMed · Cited by 64
Szatrowski, T. P., Dodge, R. K., Reynolds, C., Westbrook, C. A., Frankel, S. R., Sklar, J., Stewart, C. C., Hurd, D. D., Kolitz, J. E., Vélez-García, E., et al. (2003) · Cancer · doi:10.1002/cncr.11219 · Cited by 63
Huang, X., Bennett, M. A., & Thorpe, P. E. (2004) · The Prostate · doi:10.1002/pros.20074 · Cited by 63
Multani, P. S., O'Day, S. J., Nadler, L. M., & Grossbard, M. L. (1998) · PubMed · Cited by 61
Li, Q., Verschraegen, C. F., Mendoza, J. T., et al. (2004) · PubMed · Cited by 59
Tur, M. K., Hühn, M., Thepen, T., Stöcker, M., Krohn, R. M., Vogel, S., Jost, E., Osieka, R., van de Winkel, J. G. J., Fischer, R., et al. (2003) · PubMed · Cited by 58
Lanza, Castoldi, Castagnar, Todd, Moretti, Spisani, Latorraca, Focarile, Roberti, & Traniello (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00932.x · Cited by 57
Phan, L. D., Perentesis, J. P., & Bodley, J. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52926-4 · Cited by 55
A Phase II Study of the Immunotoxin N901-Blocked Ricin in Small-Cell Lung Cancer
Fidias, P. M., Grossbard, M. L., & Lynch, T. J. (2002) · Clinical Lung Cancer · doi:10.3816/clc.2002.n.006 · Cited by 55
Bruell, D., Stöcker, M., Hühn, M., Redding, N., Kupper, M. B., Schumacher, P., Paetz, A., Bruns, C. J., Haisma, H. J., Fischer, R., et al. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.4.1179 · Cited by 53
Onda, M., Wang, Q., Guo, H.-F., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0570 · Cited by 53
Polito, L., Bolognesi, A., Tazzari, P. L., Farini, V., Lubelli, C., Zinzani, P. L., Ricci, F., & Stirpe, F. (2004) · Leukemia · doi:10.1038/sj.leu.2403378 · Cited by 52
Grossbard, M. L., Multani, P. S., Freedman, A. S., O'Day, S. J., Gribben, J. G., Rhuda, C., Neuberg, D. S., & Nadler, L. M. (1999) · PubMed · Cited by 49
Recombinant single-chain immunotoxins against T and B cell leukemias.
Kreitman, R. J., & Pastan, I. H. (1994) · PubMed · Cited by 48
Self-citationGrossbard, M. L., Fidias, P. M., Kinsella, J., O'toole, J., Lambert, J. M., Blättler, W. A., Esseltine, D. L., Braman, G. M., Nadler, L. M., & Anderson, K. C. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00799.x · Cited by 47
Development and Pharmacokinetics and Pharmacodynamics of Pegylated Interferon Alfa-2a (40 kD)
Reddy, K. R. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-832926 · Cited by 46
Fabbrini, M. S., Carpani, D., Rivero, I. B., & Soria, M. R. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367352 · Cited by 42
Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma
Scadden, D. T., Schenkein, D. P., Bernstein, Z. P., Luskey, B., Doweiko, J. P., Tulpule, A., & Levine, A. M. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12<2580::aid-cncr25>3.0.co;2-c · Cited by 42
Fan, D., Yano, S., Shinohara, H., Solórzano, C. C., Arsdall, M. R. V., Bucana, C. D., Pathak, S., Kruzel, E., Herbst, R. S., Onn, A., et al. (2002) · PubMed · Cited by 42
Rajagopal, V., & Kreitman, R. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7566 · Cited by 41
Self-citationDecker, T. W., Hipp, S., Kreitman, R. J., Pastan, I. H., Peschel, C., & Licht, T. (2002) · Blood · doi:10.1182/blood.v99.4.1320.h8001320_1320_1326 · Cited by 40
Self-citationNovel anti-CD30 recombinant immunotoxins containing disulfide-stabilized Fv fragments.
Nagata, S., Onda, M., Numata, Y., Santora, K., Beers, R., Kreitman, R. J., & Pastan, I. H. (2002) · PubMed · Cited by 36
Self-citationRustamzadeh, E., Li, C., Doumbia, S., Hall, W. A., & Vallera, D. A. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026238331739 · Cited by 35
Immunotoxin Therapy of Small-Cell Lung Cancer
Lynch, T. J. (1993) · CHEST Journal · doi:10.1378/chest.103.4_supplement.436s · Cited by 34
Duvic, M. A. (2000) · Clinical Lymphoma · doi:10.3816/clm.2000.s.010 · Cited by 31
Zhong, R., van de Winkel, J. G. J., Thepen, T., Schultz, L. D., & Ball, E. (2001) · Stem Cells and Development · doi:10.1089/152581601750098318 · Cited by 31
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
Nabhan, C., & Tallman, M. S. (2002) · Clinical Lymphoma · doi:10.3816/clm.2002.s.004 · Cited by 31
Retinoic acid-induced CD38 antigen as a target for immunotoxin-mediated killing of leukemia cells
Mehta, K., Ocanas, L., Malavasi, F., Marks, J. W., & Rosenblum, M. G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.345.3.3 · Cited by 30
Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer
Epstein, C., Lynch, T., Shefner, J. M., Wen, P. Y., Maxted, D., Braman, V. M., Ariniello, P. D., Coral, F., & Ritz, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570712 · Cited by 28
Nagata, S., Numata, Y., Onda, M., Ise, T., Hahn, Y., Lee, B., & Pastan, I. H. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.009 · Cited by 27
Mohanraj, D., & Ramakrishnan, S. (1995) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(94)00166-u · Cited by 26
Jin, N., Chen, W., Blazar, B. R., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340252809793 · Cited by 25
Clinical Trials with Blocked Ricin Immunotoxins
O’Toolei, J. E., Esseltine, D. L., Lynch, T. J., Lambert, J. M., & Grossbard, M. L. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-72153-3_3 · Cited by 25
Kreitman, R. J., & Pastan, I. H. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00024a025 · Cited by 24
Self-citationMesri, E. A., Kreitman, R. J., Fu, Y., Epstein, S. E., & Pastan, I. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53475-x · Cited by 21
Self-citationMesri, E. A., Ōno, M., Kreitman, R. J., Klagsbrun, M., & Pastan, I. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.9.2599 · Cited by 18
Self-citationHsing (1996) · doi:10.1002/(sici)1097-0215(19960208)65:4 · Cited by 1
Cited by
Fusion protein linkers: Property, design and functionality
Chen, X., Zaro, J. L., & Shen, W.-C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.039 · Cited by 2,056
The Different Mechanisms of Cancer Drug Resistance: A Brief Review
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.041 · Cited by 1,883
Shen, B.-Q., Xu, K., Liu, L., Raab, H., Bhakta, S., Kenrick, M., Parsons-Reponte, K. L., Tien, J., Yu, S.-F., Mai, E., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2108 · Cited by 1,008
Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Bannas, P., Hambach, J., & Koch-Nolte, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01603 · Cited by 572
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
Metadata
- Authors
- Kreitman, R. J.
- Venue
- The AAPS Journal
- Published
- 2006-09
- Volume
- 8
- Issue
- 3
- Pages
- E532-E551
- ISSN
- 1550-7416 (ISSN-L)
- OpenAlex
- W2062348697
- Cited by
- 307
- References
- 130
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.